Literature DB >> 11750837

Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions.

P Servaes1, C Verhagen, G Bleijenberg.   

Abstract

Research on the relationship between cancer and fatigue has increased considerably in recent years. In this review, we focus on fatigue observed in patients during and after treatment for cancer, using data from empirical studies. The results from these studies indicate that fatigue is mostly studied during active treatment for cancer, and is an important problem during this period. Studies that focused on fatigue in disease-free cancer patients, although less prominent, also indicate fatigue is an important complaint in this time period. It is hard to draw conclusions with regard to the relationships between fatigue and disease- and treatment-related characteristics, because these relationships are seldom properly investigated. Relationships between fatigue and psychological, social, behavioural and physical factors have been established in several studies. However, most studies focused on the depression-fatigue association. Finally, most intervention studies to reduce fatigue appear to be successful, but the follow-up analyses are lacking.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11750837     DOI: 10.1016/s0959-8049(01)00332-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  138 in total

Review 1.  Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.

Authors:  Julienne E Bower; Donald M Lamkin
Journal:  Brain Behav Immun       Date:  2012-07-06       Impact factor: 7.217

2.  Cancer-related fatigue and associated disability in post-treatment cancer survivors.

Authors:  Jennifer M Jones; Karin Olson; Pamela Catton; Charles N Catton; Neil E Fleshner; Monika K Krzyzanowska; David R McCready; Rebecca K S Wong; Haiyan Jiang; Doris Howell
Journal:  J Cancer Surviv       Date:  2015-04-16       Impact factor: 4.442

3.  Identification of distinct fatigue trajectories in patients with breast cancer undergoing adjuvant chemotherapy.

Authors:  Doerte U Junghaenel; Jules Cohen; Stefan Schneider; Anu R Neerukonda; Joan E Broderick
Journal:  Support Care Cancer       Date:  2015-01-27       Impact factor: 3.603

4.  Education for cancer-related fatigue: could talking about it make people more likely to report it?

Authors:  Lisa O'Brien; Anna Loughnan; Amanda Purcell; Terry Haines
Journal:  Support Care Cancer       Date:  2013-09-13       Impact factor: 3.603

5.  Evidence for classically conditioned fatigue responses in patients receiving chemotherapy treatment for breast cancer.

Authors:  Dana H Bovbjerg; Guy H Montgomery; George Raptis
Journal:  J Behav Med       Date:  2005-06

Review 6.  Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue.

Authors:  Paul B Jacobsen; Kristine A Donovan; Susan T Vadaparampil; Brent J Small
Journal:  Health Psychol       Date:  2007-11       Impact factor: 4.267

Review 7.  The role of neuro-immune interactions in cancer-related fatigue: Biobehavioral risk factors and mechanisms.

Authors:  Julienne E Bower
Journal:  Cancer       Date:  2019-01-02       Impact factor: 6.860

8.  Factors predicting fatigue in breast cancer patients.

Authors:  Shahpar Haghighat; Mohammad Esmail Akbari; Kourosh Holakouei; Abbas Rahimi; Ali Montazeri
Journal:  Support Care Cancer       Date:  2003-05-03       Impact factor: 3.603

Review 9.  The prevalence and severity of fatigue in men with prostate cancer: a systematic review of the literature.

Authors:  Ben Langston; Jo Armes; Anneliese Levy; Elizabeth Tidey; Emma Ream
Journal:  Support Care Cancer       Date:  2013-03-03       Impact factor: 3.603

10.  Physical activity and fatigue in breast cancer survivors: a panel model examining the role of self-efficacy and depression.

Authors:  Siobhan M Phillips; Edward McAuley
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-01       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.